Key Takeaways

  • Amanda Blank, founder of Founders Beauty Group (FBG), personally secret-shopped med spa acquisition targets multiple times before closing deals to inspect provider technique and front-desk intake friction directly.
  • In clinical roll-ups governed by Corporate Practice of Medicine rules, paper diligence on clinical compliance fails to catch bedside demeanor or operational leaks between the management services organization (MSO) and clinical providers.
  • Blank found that mismanaging transaction announcements spooks clinical staff; providing advance heads-up and clear operational continuity converted clinic anxiety into the highest-performing revenue months the acquired practices had seen in years.
  • Sustained platform performance relied on aligning selling physicians and local practice managers around shared quarterly strategy rather than imposing top-down corporate mandates.

Secret Shopping Replaces Desktop Clinical Diligence

Private equity sponsors buying healthcare assets routinely spend six figures on third-party compliance reviews, billing audits, and quality-of-earnings reports. Yet none of those workstreams tell an acquirer what happens when a patient walks through the door. When Blank was building Founders Beauty Group, she skipped the comfort of third-party spreadsheets and booked appointments herself. As Blank put it, “Oh, I should have mentioned in that deal process I did a little secret shopping. You got to go test the quality of the services.”

In healthcare services, gross margins depend heavily on customer retention and clinical reputation. A single injector with poor bedside manner or an indifferent front-desk coordinator can destroy patient lifetime value long before the churn surfaces in quarterly financials. Blank used repeat visits to evaluate whether clinic revenue was tied to genuine clinical standard operating procedures or merely to the charismatic pull of an individual injector who could walk out the door post-close.

Preserving Clinical Goodwill to Unlock Immediate Revenue

Buying the practice is the easy part; retaining the licensed personnel who generate the revenue is where roll-ups routinely break. Clinical staff in aesthetic medicine hold high mobility. If an acquisition announcement feels like a corporate ambush, injectors defect to competitors and take their patient books with them.

Blank learned this tension firsthand on her initial transactions. “I mean then we came to the company we made the announcement like hello nice to meet I mean learned a lot from doing that announcement,” Blank noted. “Realized that people like to be given a heads up.”

Giving clinic personnel advance context before springing ownership changes on them altered the staff reaction entirely. Instead of facing provider walkouts or quiet quitting, Blank managed operational expectations directly. The clinic teams felt respected rather than acquired. That psychological safety generated immediate financial returns: “It was actually the best after close was the best performing months that they had had in years because everyone was so excited.”

Blank paired this staff stability with structured governance. She kept selling physicians engaged alongside practice managers to set quarterly operational strategy under the FBG umbrella. When local clinical leadership retains autonomy over care while the platform handles administrative overhead, productivity climbs instead of collapsing under corporate integration.

Why It Matters

Lower-middle-market healthcare roll-ups face compressed exit multiples when buyers suspect provider flight risk or integration friction. Blank shows that hands-on operational diligence at the patient interface protects platform value far better than abstract legal warranties. In retail healthcare, immediate post-acquisition growth depends entirely on whether front-line providers view the new owner as an administrative partner or an extractive threat.